-
Webinar recording
-
Evaluate this resource
-
Transcript
Multidisciplinary Expert Insights: Navigating DNA Damage Repair Deficiency in Cancer Patient Management
A multidisciplinary panel of clinical experts discusses a case that involves DNA repair deficiency and PARP inhibitors, including BRCA1/2 and other biomarkers, and how to make informed decisions regarding the best path forward for the patient.
Cancer biomarker testing performed for treatment decision-making can be challenging to interpret. In this educational webinar, a multidisciplinary panel of clinical experts will discuss a case that involves DNA repair deficiency and PARP inhibitors, including BRCA1/2 and other biomarkers, and how to make informed decisions regarding the best path forward for the patient.
The Jackson Laboratory is a non-profit biomedical research organization and National Cancer Institute-designated Cancer Center.
Panelists
- Emily Edelman, M.S., CGC, Director, Clinical Education Program, The Jackson Laboratory
- Christine Walko, Pharm.D., BCOP, FCCP, Associate Member, Individualized Cancer Management, Moffitt Cancer Center
- Jill M. Kolesar, Pharm.D., M.S., FCCP, BCPS, Professor, Pharmacy and Medicine, University of Kentucky
- Kelsey Fusco, M.S., CGC, Genetic Counselor, New England Cancer Specialists